Clinical Trial

GRANITE: Airsupra Effectiveness in the Real World

Study acronym: GRANITE
Completed
View on ClinicalTrials.gov →
Summary
The GRANITE study aims to evaluate the effectiveness of Airsupra versus albuterol in reducing asthma exacerbation risk in a real-world US population.
Protocol Amendment History 3 changes
critical Trial completed 2026-06-13
notable Primary completion moved earlier: 2026-06-30 -> 2026-03-20 2026-06-13
minor Completion moved earlier: 2026-06-30 -> 2026-03-20 2026-06-13
Trial Details
NCT Number NCT07141277
Lead Sponsor AstraZeneca
Conditions Asthma
Enrollment 4,060 participants
Start Date 2025-07-09
Primary Completion 2026-03-20 (estimated)
Study Completion 2026-03-20 (estimated)
Updated on ClinicalTrials.gov 2026-06-12